Showing results (41-50 of 108) with videos related to
Sort By:
Pageof 11
The Journal of Rheumatology|February 5, 2002
Collagenase-1 (MMP-1) and HLA-DRB1 gene polymorphisms in rheumatoid arthritis: a prospective longitudinal studyArnaud Constantin, Valérie Lauwers-Cancès, Frédérique Navaux, et al.International Dental Journal|May 23, 2013
Oral health-related quality of life among outpatients with rheumatoid arthritisAlessandra Blaizot, Paul Monsarrat, Arnaud Constantin, et al.Rheumatology Advances in Practice|September 25, 2025
Bone marrow oedema of the sacroiliac joint without spondyloarthritis: a retrospective study of 34 cases of osteitis condensans iliiSabine Guehery, Julian Plenard, François Lafourcade, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 14, 2019
Inhibition of Osteoclastogenesis by the RNA-Binding Protein QKI5: a Novel Approach to Protect from Bone ResorptionBenjamin Rauwel, Yannick Degboé, Katy Diallo, et al.European Radiology|May 24, 2019
Prevalence of inflammatory posterior arch abnormalities on lumbar spine MRI in spondyloarthritis patients compared with low back pain patientsHélène Braun, Clément Geniez, Yannick Degboe, et al.Frontiers in Medicine|June 6, 2022
Increased Cardiovascular Risk in Psoriatic Arthritis: Results From a Case-Control Monocentric StudyYannick Degboé, Richard Koch, Laurent Zabraniecki, et al.Rheumatology (Oxford, England)|December 25, 2012
Association between -871C>T promoter polymorphism in the B-cell activating factor gene and the response to rituximab in rheumatoid arthritis patientsAdeline Ruyssen-Witrand, Stéphanie Rouanet, Bernard Combe, et al.Annals of the Rheumatic Diseases|May 6, 2014
Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomesAdeline Ruyssen-Witrand, Gregory Guernec, Delphine Nigon, et al.Arthritis Research & Therapy|March 22, 2022
Validation in the ESPOIR cohort of vitamin K-dependent protein S (PROS) as a potential biomarker capable of predicting response to the methotrexate/etanercept combinationOlivier Vittecoq, Clément Guillou, Julie Hardouin, et al.Oral Health and Dental Management|March 8, 2014
Oral health status in outpatients with rheumatoid arthritis: the OSARA studyPaul Monsarrat, Jean-Noël Vergnes, Alessandra Blaizot, et al.Pageof 11